Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease.

Lim, S H; Hong, J Y; Lim, S T; Hong, H; Arnoud, J; Zhao, W; Yoon, D H; Tang, T; Cho, J; Park, S; Ko, Y H; Kim, S J; Suh, C; Lin, T; Kim, W S.
Ann Oncol; 28(9): 2199-2205, 2017 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-28911074